Mad in America

MAY 2, 2024

The prevailing logic goes: if we can validate biometric tests that are clinically predictive of mental health concerns like in other medical fields, we can more precisely, effectively, and without (solely) subjective clinical observation, treat the malady. Should we give up the search for biomarkers altogether?

Trauma and the brain 111

Trauma and the brain Neurotransmitters and mental health Genetics and mental health Biopsychosocial model 111

Mad in America

FEBRUARY 28, 2024

You’re also an author, and you’ve written on topics such as aging, genetics, mental representation, biological functions, mechanisms in science, and the concept of information in neuroscience. So why do we call schizophrenia a mental disorder, but not believing in conspiracy theories?

Biopsychosocial model 142

Biopsychosocial model Aging and mental health Neurotransmitters and mental health Poverty and mental health 142

Mad in America

OCTOBER 18, 2023

R ay Moynihan is an accomplished health journalist and author who has won several awards for his work. This applies in the mental illness world and everywhere in medicine. Helping widen the definitions of disease is a key part of marketing those pharmaceutical products. I started writing books. What was that about?

Pharmaceuticals 145

Pharmaceuticals Manufacturing Healthcare Neurotransmitters and mental health 145